Skip to Main Content

Paper Details

Evaluation of candidate vaccine approaches for MERS-CoV.
Nat Commun
233
2015
CoV, MERS, MERS-CoV, MERS-CoV S, Middle East respiratory syndrome coronavirus, S1, S1 subunit protein, S2 subunit, full-length S DNA, human primates, mice, murine, radiographic pneumonia, respiratory disease, rhesus macaques, viral, viral Spike (S) glycoprotein
Author NameAffiliation
Lingshu WangVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Michael G JoyceVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Kayvon Modjarrad1] Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Walter Reed Army Institute of Research, USA [3] Henry M. Jackson Foundation for the Advancement of Military Medicine
Tongqing ZhouVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
John-Paul ToddVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Mark R DenisonVanderbilt University Medical Center
Peter D KwongVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
John R MascolaVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • 1 - 8

Datasets

Release 1.2